Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in UNCY — Unicycive Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in UNCY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$750,582
-$560,279 QoQ
Shares Held
160,039
-19.7% QoQ
Ownership
0.575%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 80 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in UNCY Over Time

Shares Held

Position Value (USD)

Derivatives in UNCY

reported options exposure · as of Jun 30, 2026
CallValue
$1,570,212
CallShares
334,800
PutValue
$1,476,412
PutShares
314,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. UNCY ranks #137 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in UNCY

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $750,582 160,039
2026-06-30 $1,476,412 314,800
2026-06-30 $1,570,212 334,800
2026-03-31 $1,310,861 199,219
2026-03-31 $2,135,210 324,500
2026-03-31 $490,868 74,600
2025-12-31 $143,851 24,931
2025-12-31 $151,751 26,300